The IMID Forum

← The IMID Forum29. Okt. · 13 Min.

Discussing RA: Comparative safety and remission outcomes of targeted therapies and MTX

Discussing RA: Comparative safety and remission outcomes of targeted therapies and MTX29. Okt.13 Min.

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review papers by Ibis et al. and Russell et al. which explore how targeted therapies may improve outcomes in patients with RA.